The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Quadrivalent Influenza Vaccine (split virion, inactivated), suspension for injection in pre-filled syringeQuadrivalent influenza vaccine (split virion, inactivated)

15 microgram(s) Solution for injection in pre-filled syringe

Sanofi PasteurPA2131/013/001

Main Information

Trade NameQuadrivalent Influenza Vaccine (split virion, inactivated), suspension for injection in pre-filled syringeQuadrivalent influenza vaccine (split virion, inactivated)
Active SubstancesA/Michigan/45/2015 (H1N1)pdm09 - like strain (A/Michigan/45/2015, NYMC X-275)
A/SINGAPORE/IMFIMH-16-0019/2016 (H3N2)-LIKE STRAIN (A/SINGAPORE/INFIMH-16-0019/2016,NIB-104)
B/COLORADO/06/2017 - LIKE STRAIN (B/MARYLAND/15/2016,WILD TYPE)
B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE)
Strength15 microgram(s)
Dosage FormSolution for injection in pre-filled syringe
Licence HolderSanofi Pasteur
Licence NumberPA2131/013/001

Group Information

ATC CodeJ07BB Influenza vaccines
J07BB02 influenza, inactivated, split virus or surface antigen

Status

Authorised/WithdrawnAuthorised
Licence Issued15/07/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back